Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Gamaleya Institute ready to file documents to test new platforms for COVID vaccines

The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...

“Vector” assessed the risk of spreading a new type of coronavirus NeoCov

Experts from the Russian sanitary watchdog’s Vector center have been briefed about a new coronavirus discovered in South Africa, named NeoCov, the center said...

Pfizer Covid Pill Europe’s First Approved Oral Treatment Against Covid

Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the...

Russia approves AstraZeneca’s drug for coronavirus prophylaxis

The Russian Ministry of Health approved circulation of Evusheld, a COVID-19 prophylaxis drug by AstraZeneca, on the territory of the country, according to the...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

The Skolkovo Innovation Center has completed Phase I of a clinical trial for stomach cancer treatment

Alofanib helped to stop the development of the disease in 70% of patients. Such data were obtained during a clinical trial of an innovative...
spot_img

Expert Articles

spot_img